Zhejiang Dayang Biology Technology Co.,Ltd.
003017.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.2B
Close$
$0.35
98.4% downside
Current Fair Value
98.4% downsideOvervalued by 98.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.20 Billion |
|---|---|
| Enterprise Value | $2.26 Billion |
| Dividend Yield | $0.55 (2.65%) |
| Earnings per Share | $1.23 |
| Beta | 0.45 |
| Outstanding Shares | 100,386,811 |
Return
| Return on Equity | 9.12% |
|---|---|
| Return on Assets | 5.41% |
| Return on Invested Capital | 9.04% |
Valuation & Multiples
| P/E Ratio | 18.14 |
|---|---|
| PEG | 70.63 |
| Price to Sales | 2.02 |
| Price to Book Ratio | 2.02 |
| Enterprise Value to Revenue | 2.05 |
| Enterprise Value to EBIT | 20.2 |
| Enterprise Value to Net Income | 21 |
| Total Debt to Enterprise | 0.2 |
| Debt to Equity | 0.39 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Zhejiang Dayang Biology Technology Co.,Ltd.
771 employees
CEO: Xujun Chen Zhejiang Dayang Biology Technology Co.,Ltd. is a diversified enterprise specializing in the research, development, manufacturing, and global distribution of biological products, agricultural chemicals, and a broad spectrum of chemical co...